RE: Share price strength! More resiliant than my other shares!!26 Oct 2023 11:28
I find the research into cancer that the Angles's parsortix machine is now enabling extremely interesting.
Labs now being able to relatively easily capture a single circulating tumour cell (CTC) from a standard blood sample for study is slowly but surely reaping rewards. Only "scratching the surface" I think. The molecular analysis Companies who offer cancer treatment guidance aleady based on information from DEAD cancer cells simply must be urgently investigating what additional information similar analysis of the LIVE cancer cells can give them!
Plus that is only one of the many potential ways capturing CTC's could drive revenue up for Angle.
RE: Share price strength! More resiliant than my other shares!!23 Oct 2023 14:54
In retrospect clearly the placing @ 80p back in July 2022 was based on hugely optimistic sales expectations.
Setting up and staffing other labs in the World and finding and agreeing contracts with enough distributors throught the World cannot be done in months which now seems pretty obvious. However substancial money was raised. My reading of Angle is they are only now starting to see the fruits of their labour. Other Pharma Co's must be following Angle's progress and starting to evaluate how Angle's Parsortix(R) system will affect the cancer treatment market. Being able to separate out a single circulating tumor cell (CTC) from a standard blood sample is fantastic and the information you can get from them is only now starting to become clear.
For example we now know Companies that obtain information about a persons cancer using molecular analysis of dead cancer cells (already big business) would be able to get a more complete picture of someone's existing cancer by also analysing live cancer cells collected by Angle's Parsortix(R) system. This in itself could be massive for Angle as one of the molecular analysis Companies could corner the market by doing an exclusive deal with Angle or indeed simply buy Angle outright.
- There are loads of possibilities for Angle's Parsortix(R) system. Only scratching the surface I think.